Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anika Agarwal

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Brain Research. Molecular Brain Research|May 11, 2005
Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) geneAnika Agarwal, Lisa M Halvorson, Gabor Legradi
Molecular Human Reproduction|January 31, 2002
Cloning and characterization of the human oviduct-specific glycoprotein (HuOGP) gene promoterAnika Agarwal, William S B Yeung, Kai-Fai Lee
Nature Medicine|May 10, 2005
Reversing systemic inflammatory response syndrome with chemokine receptor pepducinsNicole C Kaneider, Anika Agarwal, Andrew J Leger, et al.
Cell|February 15, 2005
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cellsAdrienne Boire, Lidija Covic, Anika Agarwal, et al.
Cancer Research|June 24, 2010
Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapyAnika Agarwal, Sarah L Tressel, Rajani Kaimal, et al.
Cancer Research|July 23, 2009
Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasisEric Yang, Adrienne Boire, Anika Agarwal, et al.
Nature Immunology|October 30, 2007
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNicole C Kaneider, Andrew J Leger, Anika Agarwal, et al.
Molecular Cancer Therapeutics|September 16, 2008
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancerAnika Agarwal, Lidija Covic, Leila M Sevigny, et al.
American Journal of Lifestyle Medicine|January 12, 2026
The Impact of Diet, Exercise and Obstructive Sleep Apnea on Atherogenic Erectile Dysfunction: An Expert ReviewKathleen E Allen, Priyansh Shah, Aaron Spitz, et al.
EMBO Molecular Medicine|May 19, 2011
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsisSarah L Tressel, Nicole C Kaneider, Shogo Kasuda, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Brain Research. Molecular Brain Research|May 11, 2005
Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) geneAnika Agarwal, Lisa M Halvorson, Gabor Legradi
Molecular Human Reproduction|January 31, 2002
Cloning and characterization of the human oviduct-specific glycoprotein (HuOGP) gene promoterAnika Agarwal, William S B Yeung, Kai-Fai Lee
Nature Medicine|May 10, 2005
Reversing systemic inflammatory response syndrome with chemokine receptor pepducinsNicole C Kaneider, Anika Agarwal, Andrew J Leger, et al.
Cell|February 15, 2005
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cellsAdrienne Boire, Lidija Covic, Anika Agarwal, et al.
Cancer Research|June 24, 2010
Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapyAnika Agarwal, Sarah L Tressel, Rajani Kaimal, et al.
Cancer Research|July 23, 2009
Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasisEric Yang, Adrienne Boire, Anika Agarwal, et al.
Nature Immunology|October 30, 2007
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNicole C Kaneider, Andrew J Leger, Anika Agarwal, et al.
Molecular Cancer Therapeutics|September 16, 2008
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancerAnika Agarwal, Lidija Covic, Leila M Sevigny, et al.
American Journal of Lifestyle Medicine|January 12, 2026
The Impact of Diet, Exercise and Obstructive Sleep Apnea on Atherogenic Erectile Dysfunction: An Expert ReviewKathleen E Allen, Priyansh Shah, Aaron Spitz, et al.
EMBO Molecular Medicine|May 19, 2011
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsisSarah L Tressel, Nicole C Kaneider, Shogo Kasuda, et al.
Pageof 3